# Erythropoietin Therapy for Subarachnoid Hemorrhage

> **NCT00140010** · PHASE2 · COMPLETED · sponsor: **University of Cambridge** · enrollment: 80 (actual)

## Conditions studied

- Aneurysmal Subarachnoid Hemorrhage

## Interventions

- **DRUG:** erythropoietin beta

## Key facts

- **NCT ID:** NCT00140010
- **Lead sponsor:** University of Cambridge
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2009-05-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00140010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00140010, "Erythropoietin Therapy for Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00140010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*